» Articles » PMID: 36008947

GraphSite: Ligand Binding Site Classification with Deep Graph Learning

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Aug 26
PMID 36008947
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of small organic molecules to protein targets is fundamental to a wide array of cellular functions. It is also routinely exploited to develop new therapeutic strategies against a variety of diseases. On that account, the ability to effectively detect and classify ligand binding sites in proteins is of paramount importance to modern structure-based drug discovery. These complex and non-trivial tasks require sophisticated algorithms from the field of artificial intelligence to achieve a high prediction accuracy. In this communication, we describe GraphSite, a deep learning-based method utilizing a graph representation of local protein structures and a state-of-the-art graph neural network to classify ligand binding sites. Using neural weighted message passing layers to effectively capture the structural, physicochemical, and evolutionary characteristics of binding pockets mitigates model overfitting and improves the classification accuracy. Indeed, comprehensive cross-validation benchmarks against a large dataset of binding pockets belonging to 14 diverse functional classes demonstrate that GraphSite yields the class-weighted F1-score of 81.7%, outperforming other approaches such as molecular docking and binding site matching. Further, it also generalizes well to unseen data with the F1-score of 70.7%, which is the expected performance in real-world applications. We also discuss new directions to improve and extend GraphSite in the future.

Citing Articles

Improving Identification of Drug-Target Binding Sites Based on Structures of Targets Using Residual Graph Transformer Network.

Lv S, Zeng X, Su G, Du W, Li Y, Wen M Biomolecules. 2025; 15(2).

PMID: 40001524 PMC: 11853427. DOI: 10.3390/biom15020221.


NABhClassifier Server: A Tool for the Identification of Helical Nucleic Acid-Binding Sequences in Proteins.

Margis R, Macedo I, Rodrigues N, Dias-Oliveira M, Lazzarotto F, Trindade de Souza D J Chem Inf Model. 2025; 65(5):2361-2367.

PMID: 39985437 PMC: 11898072. DOI: 10.1021/acs.jcim.4c02244.


Twenty years of advances in prediction of nucleic acid-binding residues in protein sequences.

Basu S, Yu J, Kihara D, Kurgan L Brief Bioinform. 2025; 26(1).

PMID: 39833102 PMC: 11745544. DOI: 10.1093/bib/bbaf016.


MEF-AlloSite: an accurate and robust Multimodel Ensemble Feature selection for the Allosteric Site identification model.

Ugurlu S, McDonald D, He S J Cheminform. 2024; 16(1):116.

PMID: 39444016 PMC: 11515501. DOI: 10.1186/s13321-024-00882-5.


The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.

Chakraborty C, Bhattacharya M, Lee S, Wen Z, Lo Y Mol Ther Nucleic Acids. 2024; 35(3):102295.

PMID: 39257717 PMC: 11386122. DOI: 10.1016/j.omtn.2024.102295.


References
1.
Govindaraj R, Naderi M, Singha M, Lemoine J, Brylinski M . Large-scale computational drug repositioning to find treatments for rare diseases. NPJ Syst Biol Appl. 2018; 4:13. PMC: 5847522. DOI: 10.1038/s41540-018-0050-7. View

2.
Ngan C, Bohnuud T, Mottarella S, Beglov D, Villar E, Hall D . FTMAP: extended protein mapping with user-selected probe molecules. Nucleic Acids Res. 2012; 40(Web Server issue):W271-5. PMC: 3394268. DOI: 10.1093/nar/gks441. View

3.
Simonovsky M, Meyers J . DeeplyTough: Learning Structural Comparison of Protein Binding Sites. J Chem Inf Model. 2020; 60(4):2356-2366. DOI: 10.1021/acs.jcim.9b00554. View

4.
Naderi M, Lemoine J, Govindaraj R, Kana O, Feinstein W, Brylinski M . Binding site matching in rational drug design: algorithms and applications. Brief Bioinform. 2018; 20(6):2167-2184. PMC: 6954434. DOI: 10.1093/bib/bby078. View

5.
Summerton J, Weller D . Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 1997; 7(3):187-95. DOI: 10.1089/oli.1.1997.7.187. View